Merz Pharms patent expiration
1. Cuvposa patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7638552 | MERZ PHARMS | Method for increasing the bioavailability of glycopyrrolate |
Aug, 2023
(11 months ago) | |
| US7816396 | MERZ PHARMS | Method for increasing the bioavailability of glycopyrrolate |
Aug, 2023
(11 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jul 28, 2013 |
| Orphan Drug Exclusivity(ODE) | Jul 28, 2017 |
Drugs and Companies using GLYCOPYRROLATE ingredient
Market Authorisation Date: 28 July, 2010
Treatment: Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling
Dosage: SOLUTION
How can I launch a generic of CUVPOSA before it's drug patent expiration?
More Information on Dosage
CUVPOSA family patents
